Shahidi Javad 4
4 · Centessa Pharmaceuticals plc · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Shahidi Javad
Chief Medical Officer
Transactions
- Award
Share Option (right to buy)
2022-04-01+330,000→ 330,000 totalExercise: $9.08Exp: 2032-04-01→ Ordinary Shares (330,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on April 1, 2023 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.